Cingulate Inc. (CING)
NASDAQ: CING · Real-Time Price · USD
5.20
-0.05 (-0.95%)
At close: Aug 11, 2026, 4:00 PM EDT
5.06
-0.14 (-2.69%)
After-hours: Aug 11, 2026, 5:46 PM EDT
Cingulate Market Cap
Cingulate has a market cap or net worth of $70.04 million as of August 11, 2026. Its market cap has increased by 219.03% in one year.
Market Cap
70.04M
Enterprise Value
51.57M
1-Year Change
219.03%
Ranking
Category
Stock Price
$5.20
ChartMarket Cap Chart
Since the IPO on December 8, 2021, Cingulate's market cap has increased from $64.29M to $70.04M, an increase of 8.95%. That is a compound annual growth rate of 1.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 70.04M | 138.83% |
| Dec 31, 2025 | 29.33M | 80.15% |
| Dec 31, 2024 | 16.28M | 127.09% |
| Dec 29, 2023 | 7.17M | -36.62% |
| Dec 30, 2022 | 11.31M | -63.77% |
| Dec 31, 2021 | 31.21M | -51.44% |
| Dec 8, 2021 | 64.29M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Elicio Therapeutics | 74.81M |
| Acrivon Therapeutics | 74.05M |
| Inovio Pharmaceuticals | 73.24M |
| Spero Therapeutics | 72.96M |
| LeonaBio | 72.14M |
| Champions Oncology | 72.11M |
| OS Therapies | 71.26M |
| Eloxx Pharmaceuticals | 70.92M |